Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

IPSS-M for Transplant Decision Making of Patients with Myelodysplastic Syndromes: A Retrospective Single-Center Study

Annalisa Condorelli, Silvia Salmoiraghi, Chiara Pavoni, Matteo Raviglione, Alessia Civini, Alessandro Putelli, Marco Frigeni, Tamara Intermesoli, Federico Lussana, Giulia Quaresmini, Marta Bellini, Maria Chiara Finazzi, Orietta Spinelli, Alessandro Rambaldi

Blood (2023) 142 (Supplement 1): 6449.

https://doi.org/10.1182/blood-2023-187369

Published: 2023

Journal Articles

The Impact of Baseline Genetic Profile and Treatment on Hematological Toxicity in CEBPA -Mutated Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 4215.

https://doi.org/10.1182/blood-2023-184845

Published: 2023

Journal Articles

Improving Prediction of Early Death in Acute Promyelocytic Leukemia: External Validation Study from Italian Single Center Experience

Marco Frigeni, Leonardo Gerosa, Chiara Pavoni, Tamara Intermesoli, Giulia Quaresmini, Marta Bellini, Marta Castelli, Clara Belotti, Martina Milani, Silvia Salmoiraghi, Orietta Spinelli, Fabio Lorenzano, Alessandro Putelli, Monica Galli, Federico Lussana, Alessandro Rambaldi

Blood (2023) 142 (Supplement 1): 4232.

https://doi.org/10.1182/blood-2023-187507

Published: 2023

Journal Articles

Selected Genomic Structural Variants Refine ELN-Based Prognostic Stratification of Patients with Acute Myeloid Leukemia and Normal Karyotype

Blood (2023) 142 (Supplement 1): 4317.

https://doi.org/10.1182/blood-2023-178599

Published: 2023

Journal Articles

Training and Validation Cohorts for Predicting the Impact of High Molecular Risk Mutations after Allogeneic Stem Cell Transplantation in Myelofibrosis

Blood (2022) 140 (Supplement 1): 10622–10623.

https://doi.org/10.1182/blood-2022-162298

Published: 2022

Journal Articles

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

Blood (2020) 136 (6): 698–714.

https://doi.org/10.1182/blood.2019003062

Published: 2020

Includes: Supplemental data

Journal Articles

Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06

Blood (2019) 134 (Supplement_1): 1443.

https://doi.org/10.1182/blood-2019-124497

Published: 2019

Journal Articles

Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06

Blood (2018) 132 (Supplement 1): 434.

https://doi.org/10.1182/blood-2018-99-113869

Published: 2018

Journal Articles

Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis

Blood (2017) 129 (24): 3227–3236.

https://doi.org/10.1182/blood-2017-01-761999

Published: 2017

Includes: Supplemental data

Journal Articles

Differences in Clinical and Molecular Characteristics and Outcome in Prefibrotic and Overt Primary Myelofibrosis According to 2016 WHO Criteria. a Study on 639 Patients of the Agimm Group

Paola Guglielmelli, PhDMD, Giada Rotunno, MSc, PhD, Annalisa Pacilli, PhD, Elisa Rumi, MD, Vittorio Rosti, Federica Delaini, MD, Margherita Maffioli, MD, Tiziana Fanelli, MSc, Alessandro Pancrazzi, BS, Lisa Pieri, MD PhD, Daniela Pietra, PhD, Silvia Salmoiraghi, BSc, Carmela Mannarelli, MSc, PhD, Francesco Passamonti, MD, Alessandro Rambaldi, MD, Giovanni Barosi, Tiziano Barbui, MD, Mario Cazzola, MD, Alessandro M. Vannucchi, MD

Blood (2016) 128 (22): 943.

https://doi.org/10.1182/blood.V128.22.943.943

Published: 2016

Journal Articles

Integrative Analysis of Copy Number and Gene Expression Data Suggests Novel Pathogenetic Mechanisms in Primary Myelofibrosis

Blood (2015) 126 (23): 2830.

https://doi.org/10.1182/blood.V126.23.2830.2830

Published: 2015

Journal Articles

Calreticulin Mutation Is Associated with Milder Disease in Patients with Post Essential Thrombocythemia Myelofibrosis (PET-MF) Compared with JAK2 V617F Mutation: A Study from the AGIMM Group

Blood (2014) 124 (21): 3179.

https://doi.org/10.1182/blood.V124.21.3179.3179

Published: 2014

Journal Articles

Mutation-Enhanced International Prognostic Scoring System (MIPSS) for Primary Myelofibrosis: An AGIMM & IWG-MRT Project

Blood (2014) 124 (21): 405.

https://doi.org/10.1182/blood.V124.21.405.405

Published: 2014

Journal Articles

Calreticulin Mutation Does Not Modify the International Prognostic Score for Predicting the Risk of Thrombosis Among 1,150 Patients with Essential Thrombocythemia

Guido Finazzi, MD, Alessandra Carobbio, MSc, Paola Guglielmelli, PhDMD, Elisa Rumi, MD, Silvia Salmoiraghi, BiolSc, Alessandro M. Vannucchi, MD, Mario Cazzola, MD, Francesco Passamonti, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD

Blood (2014) 124 (21): 404.

https://doi.org/10.1182/blood.V124.21.404.404

Published: 2014

Journal Articles

Next Generation Sequencing (NGS) of TP53 Gene Allows to Identify a Very High Risk Group of Philadelphia Negative Acute Lymphoblastic Leukemia (ALL) Patients

Silvia Salmoiraghi, BiolSc, Greta Ubiali, BiolSc, Manuela Tosi, BiolSc, Barbara Peruta, BiolSc, Marie Lorena Guinea Montalvo, BiolSc, Elena Oldani, BiolSc, Cristina Boschini, MSc, Alexander Kohlmann, PhD, Sabina Chiaretti, Tamara Intermesoli, MD, Renato Bassan, MD, Orietta Spinelli, PhD, Alessandro Rambaldi

Blood (2014) 124 (21): 3796.

https://doi.org/10.1182/blood.V124.21.3796.3796

Published: 2014

Journal Articles

Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia

Guido Finazzi, Alessandra Carobbio, Paola Guglielmelli, Chiara Cavalloni, Silvia Salmoiraghi, Alessandro M. Vannucchi, Mario Cazzola, Francesco Passamonti, Alessandro Rambaldi, Tiziano Barbui

Blood (2014) 124 (16): 2611–2612.

https://doi.org/10.1182/blood-2014-08-596676

Published: 2014

Journal Articles

miRNA-mRNA integrative analysis in primary myelofibrosis CD34 + cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis

Blood (2014) 124 (13): e21–e32.

https://doi.org/10.1182/blood-2013-12-544197

Published: 2014

Includes: Supplemental data

Journal Articles

Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis

Blood (2013) 122 (21): 1600.

https://doi.org/10.1182/blood.V122.21.1600.1600

Published: 2013

Journal Articles

Ultra Rapid, One Step Molecular Detection of BCR-ABL Major and Minor Transcripts by Isothermal RT-Loop Mediated Amplification Reaction.

Elena D'agostini, Giulia Minnucci, PhD, Giulia Amicarelli, PhD, Cinzia Pultrone, Veronica Tettamanzi, Chiara Boroni, Silvia Salmoiraghi, Orietta Spinelli, PhD, Francesco Colotta, MD, Alessandro Rambaldi, MD

Blood (2012) 120 (21): 2515.

https://doi.org/10.1182/blood.V120.21.2515.2515

Published: 2012

Journal Articles

Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis.

Blood (2012) 120 (21): 2854.

https://doi.org/10.1182/blood.V120.21.2854.2854

Published: 2012

NARROW

IPSS-M for Transplant Decision Making of Patients with Myelodysplastic Syndromes: A Retrospective Single-Center Study

The Impact of Baseline Genetic Profile and Treatment on Hematological Toxicity in CEBPA -Mutated Acute Myeloid Leukemia

Improving Prediction of Early Death in Acute Promyelocytic Leukemia: External Validation Study from Italian Single Center Experience

Selected Genomic Structural Variants Refine ELN-Based Prognostic Stratification of Patients with Acute Myeloid Leukemia and Normal Karyotype

Training and Validation Cohorts for Predicting the Impact of High Molecular Risk Mutations after Allogeneic Stem Cell Transplantation in Myelofibrosis

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06

Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06

Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis

Differences in Clinical and Molecular Characteristics and Outcome in Prefibrotic and Overt Primary Myelofibrosis According to 2016 WHO Criteria. a Study on 639 Patients of the Agimm Group

Integrative Analysis of Copy Number and Gene Expression Data Suggests Novel Pathogenetic Mechanisms in Primary Myelofibrosis

Calreticulin Mutation Is Associated with Milder Disease in Patients with Post Essential Thrombocythemia Myelofibrosis (PET-MF) Compared with JAK2 V617F Mutation: A Study from the AGIMM Group

Mutation-Enhanced International Prognostic Scoring System (MIPSS) for Primary Myelofibrosis: An AGIMM & IWG-MRT Project

Calreticulin Mutation Does Not Modify the International Prognostic Score for Predicting the Risk of Thrombosis Among 1,150 Patients with Essential Thrombocythemia

Next Generation Sequencing (NGS) of TP53 Gene Allows to Identify a Very High Risk Group of Philadelphia Negative Acute Lymphoblastic Leukemia (ALL) Patients

Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia

miRNA-mRNA integrative analysis in primary myelofibrosis CD34 + cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis

Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis

Ultra Rapid, One Step Molecular Detection of BCR-ABL Major and Minor Transcripts by Isothermal RT-Loop Mediated Amplification Reaction.

Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only